ZFAND6 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 9.99200722162641E-15 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
9.0641050221052E-11 |
Normal-vs-Stage2 |
1.958570E-03 |
Normal-vs-Stage3 |
1.73427938676696E-12 |
Normal-vs-Stage4 |
1.18810516980261E-11 |
Stage1-vs-Stage2 |
7.541800E-01 |
Stage1-vs-Stage3 |
3.435700E-03 |
Stage1-vs-Stage4 |
1.717690E-02 |
Stage2-vs-Stage3 |
3.504400E-02 |
Stage2-vs-Stage4 |
9.411700E-02 |
Stage3-vs-Stage4 |
6.846600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.63458135915562E-12 |
Normal-vs-AfricanAmerican |
1.04820000002004E-06 |
Normal-vs-Asian |
2.057000E-01 |
Caucasian-vs-AfricanAmerican |
6.956400E-01 |
Caucasian-vs-Asian |
5.940400E-01 |
AfricanAmerican-vs-Asian |
6.910600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.626032641866E-12 |
Normal-vs-Female |
1.6300000238445E-09 |
Male-vs-Female |
6.279800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.39079858740843E-11 |
Normal-vs-Age(41-60Yrs) |
5.49710277297777E-11 |
Normal-vs-Age(61-80Yrs) |
9.04831765069503E-14 |
Normal-vs-Age(81-100Yrs) |
4.944500E-03 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.843600E-02 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.588200E-02 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.013800E-02 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.431600E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.849400E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.679800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
2.349900E-02 |
Normal-vs-Grade 2 |
1.37400002486743E-09 |
Normal-vs-Grade 3 |
5.99520433297585E-15 |
Normal-vs-Grade 4 |
1.65067959301268E-12 |
Grade 1-vs-Grade 2 |
5.175600E-01 |
Grade 1-vs-Grade 3 |
1.359180E-01 |
Grade 1-vs-Grade 4 |
2.093800E-02 |
Grade 2-vs-Grade 3 |
4.504000E-02 |
Grade 2-vs-Grade 4 |
1.279050E-03 |
Grade 3-vs-Grade 4 |
9.365500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
3.49369999597116E-08 |
Normal-vs-ccB subtype |
8.54016857232409E-12 |
ccA subtype-vs-ccB subtype |
1.841900E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
2.9727997841178E-11 |
Normal-vs-N1 |
8.096700E-03 |
N0-vs-N1 |
5.680800E-01 |
|
|